Adam C. Berger

Rutgers, The State University of New Jersey

Papers

Total Citations

H-Index

About

Adam C. Berger is a surgical oncologist whose research focuses on improving outcomes for patients with pancreatic and other gastrointestinal malignancies, with a particular emphasis on the inflammatory and immunologic responses to surgery. His work investigates how minimally invasive surgical techniques, such as laparoscopic and robotic distal pancreatectomy, can reduce postoperative systemic inflammation. In his most cited study, Berger demonstrated that minimally invasive distal pancreatectomy is associated with a significantly decreased postoperative neutrophil-to-lymphocyte ratio (NLR), a key marker of inflammation and a known prognostic factor in cancer. This finding suggests that less invasive approaches may confer immunologic benefits that could translate into improved recovery and long-term outcomes. While his citation counts are still growing, reflecting an early-career trajectory, Berger’s contributions are notable for bridging surgical technique with tumor biology and host immunity. His work has been published in leading surgical journals and presented at major national meetings, positioning him as an emerging voice in the field of minimally invasive pancreatic surgery and perioperative immunomodulation.